Literature DB >> 14715666

Modulation of amyloid precursor protein cleavage by cellular sphingolipids.

Naoya Sawamura1, Mihee Ko, Wenxin Yu, Kun Zou, Kentaro Hanada, Toshiharu Suzuki, Jian-Sheng Gong, Katsuhiko Yanagisawa, Makoto Michikawa.   

Abstract

Lipid rafts and their component, cholesterol, modulate the processing of beta-amyloid precursor protein (APP). However, the role of sphingolipids, another major component of lipid rafts, in APP processing remains undetermined. Here we report the effect of sphingolipid deficiency on APP processing in Chinese hamster ovary cells treated with a specific inhibitor of serine palmitoyltransferase, which catalyzes the first step of sphingolipid biosynthesis, and in a mutant LY-B strain defective in the LCB1 subunit of serine palmitoyltransferase. We found that in sphingolipid-deficient cells, the secretion of soluble APPalpha (sAPPalpha) and the generation of C-terminal fragment cleaved at alpha-site dramatically increased, whereas beta-cleavage activity remained unchanged, and the epsilon-cleavage activity decreased without alteration of the total APP level. The secretion of amyloid beta-protein 42 increased in sphingolipid-deficient cells, whereas that of amyloid beta-protein 40 did not. All of these alterations were restored in sphingolipid-deficient cells by adding exogenous sphingosine and in LY-B cells by transfection with cLCB1. Sphingolipid deficiency increased MAPK/ERK activity and a specific inhibitor of MAPK kinase, PD98059, restored sAPPalpha level, indicating that sphingolipid deficiency enhances sAPPalpha secretion via activation of MAPK/ERK pathway. These results suggest that not only the cellular level of cholesterol but also that of sphingolipids may be involved in the pathological process of Alzheimer's disease by modulating APP cleavage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715666     DOI: 10.1074/jbc.M309832200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

2.  Effects of fatty acid unsaturation numbers on membrane fluidity and α-secretase-dependent amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Wenwen Sheng; Grace Y Sun; James C-M Lee
Journal:  Neurochem Int       Date:  2010-12-22       Impact factor: 3.921

Review 3.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 4.  Substrate specificity of gamma-secretase and other intramembrane proteases.

Authors:  A J Beel; C R Sanders
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

Review 5.  Roles of AMP-activated protein kinase in Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Keshen Li; Sohel H Quazi; Bin Zhao
Journal:  Neuromolecular Med       Date:  2012-02-26       Impact factor: 3.843

Review 6.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

7.  A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse.

Authors:  Naoya Sawamura; Takako Sawamura-Yamamoto; Yuji Ozeki; Christopher A Ross; Akira Sawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

8.  Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin.

Authors:  Hiroyuki Nakamura; Shigeo Wakita; Akiko Suganami; Yutaka Tamura; Kentaro Hanada; Toshihiko Murayama
Journal:  J Lipid Res       Date:  2009-10-16       Impact factor: 5.922

Review 9.  Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease.

Authors:  Anna Colell; Anna Fernández; José C Fernández-Checa
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

10.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.